Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
01 15Smart & Biggar LLP
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2023-05-19
Date Granted : 2012-03-13
Brand Name : VERAFLOX
Patent Number : 2487648
Filing Date : 2003-05-19
Strength per Unit : 25 mg / mL
Dosage Form : SUSPENSION
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2023-05-19
Date Granted : 2012-03-13
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2017-02-12
Date Granted : 2005-11-08
Brand Name : VERAFLOX
Patent Number : 2247020
Filing Date : 1997-02-12
Strength per Unit : 25 mg / mL
Dosage Form : SUSPENSION
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2017-02-12
Date Granted : 2005-11-08
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2015-11-03
Date Granted : 1998-11-03
Brand Name : VERAFLOX
Patent Number : 1340114
Filing Date : 1989-07-13
Strength per Unit : 25 mg / mL
Dosage Form : SUSPENSION
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2015-11-03
Date Granted : 1998-11-03
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2017-02-12
Date Granted : 2005-11-08
Brand Name : VERAFLOX
Patent Number : 2247020
Filing Date : 1997-02-12
Strength per Unit : 15 mg
Dosage Form : TABLET
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2017-02-12
Date Granted : 2005-11-08
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2015-11-03
Date Granted : 1998-11-03
Brand Name : VERAFLOX
Patent Number : 1340114
Filing Date : 1989-07-13
Strength per Unit : 15 mg
Dosage Form : TABLET
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2015-11-03
Date Granted : 1998-11-03
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2019-11-15
Date Granted : 2011-02-01
Brand Name : VERAFLOX
Patent Number : 2351707
Filing Date : 1999-11-15
Strength per Unit : 15 mg
Dosage Form : TABLET
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2019-11-15
Date Granted : 2011-02-01
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2024-10-30
Date Granted : 2013-10-15
Brand Name : VERAFLOX
Patent Number : 2544344
Filing Date : 2004-10-30
Strength per Unit : 15 mg
Dosage Form : TABLET
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2024-10-30
Date Granted : 2013-10-15
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2019-11-15
Date Granted : 2011-02-01
Brand Name : VERAFLOX
Patent Number : 2351707
Filing Date : 1999-11-15
Strength per Unit : 60 mg
Dosage Form : TABLET
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2019-11-15
Date Granted : 2011-02-01
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2024-10-30
Date Granted : 2013-10-15
Brand Name : VERAFLOX
Patent Number : 2544344
Filing Date : 2004-10-30
Strength per Unit : 60 mg
Dosage Form : TABLET
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2024-10-30
Date Granted : 2013-10-15
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2017-02-12
Date Granted : 2005-11-08
Brand Name : VERAFLOX
Patent Number : 2247020
Filing Date : 1997-02-12
Strength per Unit : 60 mg
Dosage Form : TABLET
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2017-02-12
Date Granted : 2005-11-08
